Beginning of June, VelaLabs Austria, part of the Tentamus Pharma division, acquired the pharmaceutical test laboratory Laboratorium f
?The sustainable merger with VelaLabs and, in the background, the umbrella of the Tentamus Pharma group enables us to expand our expertise and offer our clients even more different services, know-how and consulting? explains Ms. Helga Weisse, LABH Managing Director, about the motivation to take this important step. ?The location of LABH in Vienna will stay the same for now and the operational processes, contact persons and employees will serve existing and future customers in the same way as before?, so Ms. Weisse further. ?It was our goal to close a gap in our service portfolio ? microbiology. Now, we are able to offer a real one-stop shop to our valued customers and we therefore heartily welcome the team of LABH on board? says Markus Fido, CEO of VelaLabs.
LABH, founded in 2003, is a GMP-certified pharmaceutical control laboratory in accordance with AMG
Numerous recognized (bio)pharmaceutical companies are among long-lasting customers and also in the field of accreditation, valued client relationships exist for many years. The aim is now to proceed with the same emphasis and motivation even for a higher number of clients within the Tentamus Group.
Further information at www.LABH.at
Tentamus Group GmbH was founded in 2011. Tentamus is a global product and safety group with a core presence in Europe, UK, Israel, China, Japan and the USA. Accredited and licensed Tentamus Group tests, audits and consults on all products involving the human body (food & feed, pharmaceuticals & medical, agrochemicals, cosmetics, agriculture & environment and nutraceutical & supplements). Tentamus Group is represented in over 52 locations worldwide. More than 2,500 highly-trained staff members work in over 2.5 million square feet of laboratory and office spaces. For further information please visit www.tentamus.com.